Precision radiation boost after chemo shows promise for tough lung cancers
NCT ID NCT00945451
First seen May 10, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study looked at giving a precise, high-dose radiation treatment called CyberKnife after standard chemotherapy and radiation for people with stage III non-small cell lung cancer that could not be removed with surgery. The goal was to find the safest highest dose of CyberKnife and see how well it controlled the tumor. 35 adults took part, and the study measured side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.